Hisamitsu Of Japan Sees 46 Percent Profit Increase By Early 2014
This article was originally published in PharmAsia News
Executive Summary
Japan's Hisamitsu Pharmaceutical has mapped out a business plan it says should triple the company's stock dividends by February 2014. Hisamitsu credits its recent acquisition of U.S. drug maker Noven Pharmaceutical. That purchase, Hisamitsu said, helped drive up earnings, and it now expects a net profit by the end of fiscal 2013 that is anticipated to be 46 percent higher than projected for fiscal 2008. (Click here for more - a subscription may be required